Smartkarma | Intelligent Investing

This is our first inaugural issue of Korea Sector ETFs Weekly. There are two main purposes of this weekly insight.  This weekly report tracks share price performance for Korea’s 23 major sector ETFs. It helps investors identify market trends by revealing exactly which sectors are outperforming or underperforming. Second, tracking sector ETF performance reveals early clues about...

On Aug.7, 2026, Atossa Therapeutics, Inc. (ATOS) announced financial results for the second quarter of 2026 and provided a business update.The company is approaching a potentially transformative period as two Phase 2 studies of (Z)-endoxifen are expected to produce data by year-end.

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the world.Through its proprietary TAAP technology Ensysce is in the process of receiving approval for an abuse-resistant yet still pain-relieving opioid. The company announced its 2Q financial results and showed that ENSC is in solid fiscal shape headi...

Healthcare Triangle, Inc. (HCTI) operates at the intersection of healthcare delivery and cloud-based data infrastructure, positioning itself as a specialized provider of digital transformation solutions tailored to the highly regulated healthcare industry.The company's core business centers on helping hospitals, life sciences firms, and payers migrate, manage, and optimize their...

Our global intermediate-term outlook remains bullish on MSCI ACWI (in place since our 5/14/25 Compass). We also remain near-term bullish on MSCI ACWI since our 4/23/26 Int’l Compass. 2-Month base breakout on ACWI-US, MSCI EM(EEM-US) reversing its 1+month downtrend, and MSCI EAFE's(EFA-US) 5.5+ month base breakout reinforces our bullish outlook; these display bull flag patterns ...